Important Characteristics




Simple & Cost Effective


Easy to Manufacture

The proprietary lipids used in the products are produced by standard and straightforward lipid synthesis techniques.

The GMP production processes have been validated and several GMP batches successfully manufactured.

The cationic lipids are very well tolerated, and are hydrolyzed into fatty acids and excreted.

This breakdown process contributes to the excellent safety profile of the Versamune® platform.

Versamune® nanoparticles are produced using standard liposome manufacturing techniques.

Versamune® formulations eliminate the need for antigen encapsulation, further simplifying the manufacturing process.

  • About Us

    PDS Biotechnology Corporation logo image

    PDS Biotechnology is a clinical stage biopharmaceutical company developing novel cancer immunotherapies and vaccines for infectious diseases.

  • Contact Us

    PDS Biotechnology Corporation
    Commercialization Center for Innovative Technologies (CCIT)

    675 US Highway One
    North Brunswick, NJ 08902

    Tel: 732-640-0145
    Fax: 732-640-0144